Search Results 1481-1490 of 18273 for anaphylaxis

1. Publications - Philip M. Jones, M.D. - Mayo Clinic

   Mitigation of rocuronium-induced anaphylaxis by sugammadex: the great unknown. Anaesthesia 2010 Jan; 65 (1):89-90; author reply 90. View PubMed; Turkstra TP ...

2. A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma - Mayo Clinic

   -History of severe allergic or anaphylactic reactions to monoclonal antibody therapy (or recombinant antibody-related fusion proteins) -Patient with history ...

3. Phase II Single-arm Study of Tepotinib Combined with Cetuximab - Mayo Clinic

   Known severe hypersensitivity reactions to monoclonal antibodies (Grade ≥ 3 NCI-CTCAE v 5.0), any history of anaphylaxis, or uncontrolled asthma (i.e., 3 ...

4. Can you pass the penicillin allergy quiz?

   Over-reporting can lead to a number of problems including increased antibiotic resistance. Dr. Nipunie Rajapakse, a pediatric infectious diseases specialist and ...

5. A Study of Obinutuzumab to Evaluate the Safety and Tolerability in Hypersensitized Adult Participants with End Stage Renal Disease Awaiting Transplantation - Mayo Clinic

   History of severe allergic or anaphylactic reactions to monoclonal antibodies or components of obinutuzumab infusion; Participants with ESRD on peritoneal ...

6. Numbness Causes - Mayo Clinic

   Numbness is caused by damage, irritation or pressure on the nerves. A single nerve branch or several nerves may be affected. Examples include a slipped disk in ...

7. A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Known history of hypersensitivity or anaphylaxis to study intervention(s), including active product or excipient components. Requires treatment with a ...

8. Bedbugs - Symptoms and causes - Mayo Clinic

   Bedbug bites usually clear up without treatment in a week or two. Bedbugs aren't known to spread disease, but they can cause an allergic reaction or a severe ...

9. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

   The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...

10. A Study About How Platelets Adhere to the Blood von Willebrand Factor in Healthy Adults - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...